Publication: A POLICY ANALYSIS OF HOW FDA SHOULD REGULATE HUMAN BONE MARROW TRANSPLANTATION
Open/View Files
Date
1995
Authors
Published Version
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
A POLICY ANALYSIS OF HOW FDA SHOULD REGULATE HUMAN BONE MARROW TRANSPLANTATION (1995 Third Year Paper)
Research Data
Abstract
Over the past twenty years, physicians have carried out bone marrow transplants with increasing success. As the procedure gains in acceptance and availability over the coming years, our nation will be faced with important policy choices regarding the regulation of bone marrow transplantation.
Description
Other Available Sources
Keywords
Food and Drug Law, national marrow donor program, FDA, regulation
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service